Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A clinical trial of donor-derived WT1 specific T cells for prevention of relapse in combination with multiple pathogen specific T cells for prevention of infection in patients undergoing allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia
Protocol ID
INTACT-TAA
Disease (Sub Disease)
Leukaemia (AML)
Diagnosis Stage
Relapse/ refractory
Location
NSW
Sponsor
University of Sydney
Trial Status
Open
Sites
The Children's Hospital at Westmead
Study Type
Treatment
Phase
Phase 1
Age Eligibility
1 Year to 70 Years
International registry ID's
NCT02895412
Back to Registry
Study Title A clinical trial of donor-derived WT1 specific T cells for prevention of relapse in combination with multiple pathogen specific T cells for prevention of infection in patients undergoing allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia
Protocol ID INTACT-TAA
Disease (Sub Disease) Leukaemia (AML)
Diagnosis Stage Relapse/ refractory
Location NSW
Sponsor University of Sydney
Links https://clinicaltrials.gov/ct2/show/NCT02895412
Trial Status Open
Trial Open Date 01/03/2017
Sites The Children's Hospital at Westmead
Study Type Treatment
Phase Phase 1
Age Eligibility 1 Year to 70 Years
International registry ID's NCT02895412